+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evaluation of RAD50 in familial breast cancer predisposition

Evaluation of RAD50 in familial breast cancer predisposition

International Journal of Cancer 118(11): 2911-2916

The genes predisposing to familial breast cancer are largely unknown, but 5 of the 6 known genes are involved in DNA damage repair. RAD50 is part of a highly conserved complex important in recognising, signalling and repairing DNA double-strand breaks. Recently, a truncating mutation in the RAD50 gene, 687delT, was identified in 2 Finnish breast cancer families. To evaluate the contribution of RAD50 to familial breast cancer, we screened the whole coding region for mutations in 435 UK and 46 Finnish familial breast cancer cases. We identified one truncating mutation, Q350X, in one UK family. We screened a further 544 Finnish familial breast cancer cases and 560 controls for the 687delT mutation, which was present in 3 cases (0.5%) and 1 control (0.2%). Neither Q350X nor 687delT segregated with cancer in the families in which they were identified. Functional analyses suggested that RAD50 687delT is a null allele as there was no detectable expression of the mutant protein. However, the wild-type allele was retained and expressed in breast tumors from mutation carriers. The abundance of the full-length RAD50 protein was reduced in carrier lymphoblastoid cells, suggesting a possible haploinsufficiency mechanism. These data indicate that RAD50 mutations are rare in familial breast cancer and either carry no, or a very small, increased risk of cancer. Altogether, these results suggest RAD50 can only be making a very minor contribution to familial breast cancer predisposition in UK and Finland.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 048993074

Download citation: RISBibTeXText

PMID: 16385572

DOI: 10.1002/ijc.21738

Related references

Evaluation of Fanconi Anemia genes in familial breast cancer predisposition. Cancer Research 63(24): 8596-8599, 2003

Rad50 c.687delT does not contribute significantly to familial breast cancer in a French population. Cancer Epidemiology Biomarkers and Prevention 18(2): 684-685, 2009

The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators. Cancer Research 60(16): 4513-4518, 2000

Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer. Breast Cancer Research and Treatment 95(1): 73-80, 2006

Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene. Molecular Oncology 2(4): 296-316, 2008

Genetic predisposition to cancer: familial forms of medullary thyroid cancer and breast cancer. Bulletin de l'Academie Nationale de Medecine 178(1): 123-9; Discussion 129-32, 1994

Mitochondria and familial predisposition to breast cancer. Current Genomics 14(3): 195-203, 2013

Familial predisposition to breast cancer. Review. Investigacion Clinica 39(1): 53-65, 1998

Epidemiology of familial predisposition for breast cancer in Japan. Journal of the National Cancer Institute 69(6): 1229-1234, 1982

Cancer predisposition and hematopoietic failure in Rad50(S/S) mice. Genes and Development 16(17): 2237-2251, 2002

Can unknown predisposition in familial breast cancer be family-specific?. Breast Journal 19(5): 520-528, 2014

Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relatives. International Journal of Cancer 86(6): 883-887, 15 June, 2000

The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. Cancer Research 60(16): 4513-4518, 2000

Considerations for comprehensive assessment of genetic predisposition in familial breast cancer. Breast Journal 21(1): 67-75, 2015